Real-World Evidence from the Compassionate Use Programme of EHL rFVIIIFc fusion protein (efmoroctocog alfa) in the prophylaxis and treatment of bleeding in patients with haemophilia A

ALBAYRAK C., AR M. C., EYÜPOĞLU S. A., CELKAN T. T., KÜPESİZ O. A., ŞAHİN F., ...More

18th International Hemophilia Congress of Turkey, 19 September 2021

  • Publication Type: Conference Paper / Full Text
  • Ondokuz Mayıs University Affiliated: Yes